2Wrone-Smith T, Johnson T, Nelson B, et al.Discordant expression of Bcl-x and Bcl-2by keratinocytes in vitro and psoriatic keratinocytes in vivo. Am J Pathol, 1995, 146:1079-1088.
3Gregoli PA, Bondurant MC. Function of caspases in regulating apoptosis caused by erythropoietin deprivation in erythroid progenitors. J Cell Physiol, 1999, 178: 133-143.
4Bianchi L, Farrace MG, Nini G, et al. Abnormal Bcl-2 and "tissue" transglutaminase expression in psoriatic skin. J Invest Dermatol, 1994, 103: 829-833.
2[1]Bianchi L,Farrace M C,Nini G,et al.Abnormal bcl-2 and "Tissue" transglutaminase expression in psoriatic skin[J].J Invest Dermatol,1994,103 (6):829-833.
3[2]Gregoli P A.Function of capases in regulating apoptosis caused by erythropoietin deprivation in erythroid progenitors[J].J Cell Physiol,1999,178(2):133-143.
4[5]Ashcroft D M,Wanpo L,Williams H C,et al.Clinical measures of disease severity and outcome on psoriasis:acritical appraisal of the quality[J].Br J Dermatol,1999,141(2):185.
5[6]Smith C H,Jackson K,Chinn S,et al.A double blind,randomized,controlled clinical trial to assess the efficacy of a new coal tar preparation (Exorex) in the treatment of chronic,plaque type psoriasis[J].Clin Exp Dermatol,2000,25(8):580-583.
6[8]Goldsmith L A.Toads and psoriasis[J].Arch Dermatol,1986,122(8):939-940.
7[9]Wrone-smith T,Johnson T,Nelson B,et al.Discordant expression of Bcl-x and Bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo[J].Am J Pathol,1995,146(5):1079-1088.
8[10]Takahashi H,Manabe A,Ishida-Yamamoto A,et al.Aberrant expression of apoptosis-related molecules in psoriatic epidermis[J].J Dermatol Sci,2002,28 (3):187-197.
